- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript5 days agokr18.69Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr18.69Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr18.69Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
Q1 2024 Nykode Therapeutics ASA Earnings Call Transcript
Greetings, and welcome to the Nykode Therapeutics Q1 2024 financial results presentation. (Operator Instructions) As a reminder, this conference is being recorded.
Is now my pleasure to introduce Chief Executive Officer, Michael Engsig. Thank you. You may begin.
Thank you very much, Darryl and all the participants. A very warm welcome to this Q1 report that we assume you're all familiar with our forward-looking statement. And on that note we'll move forward, I am very pleased to have with me here today are Agnete Fredriksen, our Chief Scientific Officer, Head of Business Development and Co-Founder; Harald Gurvin, our Chief Financial Officer; and Klaus Edvardsen, our Chief Research and Development Officer. And together, we will take you through the highlights of the quarter as well as the financial results.
A quick look as an introduction from my side. First quarter was yet another exciting quarter with very solid progress for Nykode. We presented the very important top line
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)